COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,310 Articles (22,772 medRxiv, 8,538 bioRxiv)

Most recent first Previous |  Page 1868: Articles 18671-18680  | Next

A cross-sectional survey of the workplace factors contributing to symptoms of anxiety and depression among nurses and physicians during the first wave of COVID-19 pandemic in two US healthcare systems
Burstyn, I., Holt, K.
10.1101/2021.01.25.21250315 — Posted: 2021-01-26
ARE GEOGRAPHIC FACTORS ASSOCIATED WITH POORER OUTCOMES IN PATIENTS DIAGNOSED WITH COVID-19?
Magallon-Botaya, R., Olivan-Blazquez, B., Ramirez-Cervantes, K., Lopez-Mendez, F., Casajuana-Closas, M., Andres-Esteban, E.
10.1101/2021.01.25.21250404 — Posted: 2021-01-26
Super-Spreaders Out, Super-Spreading In: The Effects of Infectiousness Heterogeneity and Lockdowns on Herd Immunity
Tavori, J., Levy, H.
10.1101/2021.01.23.21250242 — Posted: 2021-01-26
COVID-19 Test Positivity Rate as a marker for hospital overload
Gaspari, M.
10.1101/2021.01.26.21249544 — Posted: 2021-01-26
Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data
Martinez de Salazar, P., Lu, F., Hay, J. A., Gomez-Barroso, D., Fernandez-Navarro, P., Martinez, E. V., Astray-Mochales, J., Amillategui, R., Garcia-Fulgueiras, A., Chirlaque, M. D., Sanchez-Migallon, A., Larrauri, A., Sierra, M. J., Lipsitch, M., Simon, F., Santillana, M., Hernan, M.
10.1101/2021.01.25.20230094 — Posted: 2021-01-26 Discussion: Onsite
Adaptive immunity to human coronaviruses is widespread but low in magnitude
Tan, H.-X., Lee, W. S., Wragg, K. M., Nelson, C., Esterbauer, R., Kelly, H. G., Amarasena, T., Jones, R. M., Starkey, G., Wang, B. Z., Yoshino, O., Tiang, T., Grayson, M. L., Opdam, H., D'Costa, R., Vago, A., The Austin Liver Transplant Perfusionist Group, , Mackay, L. K., Gordon, C. L., Wheatley, A. K., Kent, S. J., Juno, J. A.
10.1101/2021.01.24.21250074 — Posted: 2021-01-26
High infection attack rates of SARS-CoV-2 in Dutch households revealed by dense sampling
Reukers, D. F. M., van Boven, M., Meijer, A., Rots, N., Reusken, C., Roof, I., van Gageldonk-Lafeber, A. B., van der Hoek, W., van den Hof, S.
10.1101/2021.01.26.21250512 — Posted: 2021-01-26
Post-Disease Divergence in SARS-CoV-2 RNA Detection between Nasopharyngeal, Anterior Nares and Saliva/Oral Fluid Specimens - Significant Implications for Policy & Public Health
Turner, F., VandenBerg, A., Slepnev, V. I., Car, S., Starritt, R. E., Seger, M. V., Kojima, N., Nirema, N., Lopez, L., Brobeck, M., August, S. K., Orosco, A., Hertlein, F., Baca, A. M.
10.1101/2021.01.26.21250523 — Posted: 2021-01-26
Molecular epidemiology of SARS-CoV-2 - a regional to global perspective
Brandt, C., Spott, R., Hoelzer, M., Kuehnert, D., Fuchs, S., Lohde, M., Marquet, M., Viehweger, A., Rimek, D., Pletz, M.
10.1101/2021.01.25.21250447 — Posted: 2021-01-26
Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?
Eftekhar, S. P., Kazemi, S., Barary, M., Javanian, M., Ebrahimpour, S., Ziaei, N.
10.1101/2021.01.16.21249941 — Posted: 2021-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).